Bleeding Disorder Clinical Trials

12 recruiting

Bleeding Disorder Trials at a Glance

19 actively recruiting trials for bleeding disorder are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Early Phase 1 with 1 trial, with the heaviest enrollment activity in Seattle, Pittsburgh, and Geneva. Lead sponsors running bleeding disorder studies include American Thrombosis and Hemostasis Network, University Hospital, Geneva, and Haemophilia Foundation of Australia.

Browse bleeding disorder trials by phase

About Bleeding Disorder Clinical Trials

Looking for clinical trials for Bleeding Disorder? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bleeding Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bleeding Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study

Bleeding Disorder
University Hospital, Geneva400 enrolled7 locationsNCT05713734
Recruiting

Bleeding Disorder of Unknown Cause in the Netherlands

Hemorrhagic DisordersBleeding Disorder of Unknown Cause
Maastricht University Medical Center500 enrolled8 locationsNCT07454161
Recruiting

ATHNdataset Registry

ThrombosisSickle Cell DiseaseHemophilia A+6 more
American Thrombosis and Hemostasis Network200,000 enrolled1 locationNCT06820515
Recruiting

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

Haemophilia ACongenital Bleeding Disorder
Novo Nordisk A/S900 enrolled7 locationsNCT06574984
Recruiting

Hemophilia A Research Program

PregnancyHemophilia APregnancy Complications+10 more
University of Washington500 enrolled1 locationNCT07414511
Recruiting

National Longitudinal Cohort of Hematological Diseases

Acute Myeloid LeukemiaMultiple MyelomaMyelodysplastic Syndrome+14 more
Institute of Hematology & Blood Diseases Hospital, China2,300 enrolled1 locationNCT04645199
Recruiting
Phase 1

Recombinant vWF Concentrate and ECMO

Bleeding Disorder
University of Virginia12 enrolled1 locationNCT06118372
Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

ThrombophiliaThrombosisSickle Cell Disease+10 more
American Thrombosis and Hemostasis Network3,000 enrolled71 locationsNCT04398628
Recruiting

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Bleeding DisorderHeavy Menstrual BleedingVon Willebrand Diseases
Oregon Health and Science University300 enrolled9 locationsNCT05916469
Recruiting
Not Applicable

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Anticoagulants and Bleeding Disorders
Centre Hospitalier Régional d'Orléans30 enrolled1 locationNCT07183605
Recruiting

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

BleedingBleeding DisordersIron+1 more
Nicoletta C Machin40 enrolled1 locationNCT07083583
Recruiting

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

Multiple MyelomaMyelodysplastic SyndromeLymphoma+12 more
Yigeng Cao,MD,PhD1,000 enrolled1 locationNCT07205523
Recruiting
Early Phase 1

Early Genomic Testing for Inherited Bleeding Disorders

Bleeding Disorder
Queen's University212 enrolled3 locationsNCT06736158
Recruiting

Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics

Liver TransplantBleeding DisorderIntracranial Hemorrhages+2 more
Medical University of Vienna240 enrolled1 locationNCT06635564
Recruiting

Caudal Analgesia & Anticoagulated Patient

Lumbar Pain SyndromeAnticoagulants and Bleeding Disorders
Salem Anaesthesia Pain Clinic100 enrolled1 locationNCT05946850
Recruiting

Hormonal Management of Heavy Menstrual Bleeding in Adolescents

Bleeding DisorderHeavy Menstrual Bleeding
University Hospital, Geneva163 enrolled1 locationNCT06740929
Recruiting

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

ThrombophiliaThrombosisArterial Thromboembolism+13 more
Peking University People's Hospital3,000 enrolled5 locationsNCT06727669
Recruiting

European Rare Blood Disorders Platform (ENROL)

LeukemiaMyelomaAnemia+9 more
Hospital Universitari Vall d'Hebron Research Institute37,090 enrolled1 locationNCT06250595
Recruiting

Balance, strength and related falls risk factors in people with haemophilia and other bleeding disorders (PWH), and feasibility of a targeted home exercise program to improve balance.

Haemophilia and other bleeding disorders
Haemophilia Foundation of Australia60 enrolled1 locationACTRN12606000172505